This trial is being conducted by the University of São Paulo and aims to recruit 50 subjects suffering from Retinitis Pigmentosa between June 2011 and June 2013. All participants will receive an injection into their eye of their own bone marrow stem cells. They will be assessed regularly over the next six months and monitored for changes in vision, inflammation and abnormal cell growth such as tumours.